CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 310 filers reported holding CRISPR THERAPEUTICS AG in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,936,817 | +0.0% | 879,801 | +23.7% | 0.01% | 0.0% |
| Q2 2023 | $39,935,439 | +16.2% | 711,271 | -6.4% | 0.01% | +8.3% |
| Q1 2023 | $34,359,485 | +108998.5% | 759,735 | -1.9% | 0.01% | +33.3% |
| Q4 2022 | $31,494 | -99.9% | 774,811 | +19.4% | 0.01% | -43.8% |
| Q3 2022 | $42,414,000 | +58.6% | 649,060 | +47.5% | 0.02% | +60.0% |
| Q2 2022 | $26,738,000 | +77.5% | 439,926 | +83.3% | 0.01% | +100.0% |
| Q1 2022 | $15,067,000 | -23.3% | 239,987 | -7.4% | 0.01% | -16.7% |
| Q4 2021 | $19,636,000 | +13.4% | 259,041 | +67.5% | 0.01% | 0.0% |
| Q3 2021 | $17,311,000 | -26.6% | 154,670 | +6.1% | 0.01% | -14.3% |
| Q2 2021 | $23,584,000 | +39.6% | 145,822 | +5.1% | 0.01% | +16.7% |
| Q1 2021 | $16,897,000 | +2.4% | 138,750 | +28.9% | 0.01% | 0.0% |
| Q4 2020 | $16,496,000 | +94.0% | 107,647 | +5.9% | 0.01% | +50.0% |
| Q3 2020 | $8,505,000 | +14.5% | 101,657 | +0.6% | 0.00% | +33.3% |
| Q2 2020 | $7,425,000 | +97.8% | 101,012 | +14.2% | 0.00% | +50.0% |
| Q1 2020 | $3,754,000 | +32.5% | 88,485 | +90.2% | 0.00% | +100.0% |
| Q4 2019 | $2,834,000 | – | 46,533 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |